| Type |
Model |
Dependent Variable |
Independent Variable |
Regression Type |
R-squared |
Coefficient (95% CI) |
Standardized
Coefficient |
p-value |
| Univariate |
1 |
Exhaled H2O2 [µmol/L]
(n=19)
(detectable viral load subgroup) |
Log10 (detectable viral load) [RNA copies/mL] |
Linear |
0.23 |
0.180 (0.037 to 0.323) |
|
0.014 |
| Multivariate |
2 |
Exhaled H2O2 [µmol/L]
(n=19)
(detectable viral load subgroup:
HAART-naive and HAART-treated) |
Log10 (detectable viral load) [RNA copies/mL]
Treatment with HAARTConstant |
Linear, stepwise |
0.35 |
0.229 (0.080 to 0.377)
0.401 (0.010 to 0.791)
-0.189 (-0.818 to 0.440) |
0.6082 0.365 |
0.003 0.044 0.556 |
| 3 |
Exhaled H2O2 [µmol/L]
(n=14)
(detectable viral load subgroup:
HAART-treated only) |
Log10 (detectable viral load) [RNA copies/mL]CD4 count [cells/µL]
HIV-infection duration [yrs]
HAART duration [mths]Constant |
Linear, stepwise |
0.79 |
0.464 (0.270 to 0.659)
0.0017 (0.0003 to 0.0031)
0.155(0.011 to 0.298)
-0.015 (-0.035 to 0.003)
-1.50 (-2.56 to -0.44) |
1.162 0.938 0.932 -0.944 |
<0.001 0.015 0.035 0.110 0.005 |
HAART, highly active anti-retroviral therapy